| Literature DB >> 33911471 |
Jun-Zhou Zhao1, Lin-Lan Qiao1, Zhao-Qing Du1, Jia Zhang1, Meng-Zhou Wang1, Tao Wang1, Wu-Ming Liu1, Lin Zhang1, Jian Dong1, Zheng Wu1, Rong-Qian Wu2.
Abstract
BACKGROUND: Whether to use a T-tube for biliary anastomosis during orthotopic liver transplantation (OLT) remains a debatable question. Some surgeons chose to use a T-tube because they believed that it reduces the incidence of biliary strictures. Advances in surgical techniques during the last decades have significantly decreased the overall incidence of postoperative biliary complications. Whether using a T-tube during OLT is still associated with the reduced incidence of biliary strictures needs to be re-evaluated. AIM: To provide an updated systematic review and meta-analysis on using a T-tube during adult OLT.Entities:
Keywords: Biliary complications; Biliary strictures; Biliary tract reconstruction; Meta-analysis; Orthotopic liver transplantation; T-tube
Year: 2021 PMID: 33911471 PMCID: PMC8047534 DOI: 10.3748/wjg.v27.i14.1507
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
Figure 1Flowchart of selection process of randomized control trials and comparative studies. RCT: Randomized control trials; OLT: Orthotopic liver transplantation.
Characteristics of all studies
|
|
|
|
|
|
|
|
|
|
| López-Andújar | CS | 2019 | Y | 240 | 139/101 | 58 ± 18 | 268 ± 109 | 1 |
| N | 165 | 89/76 | 63 ± 14 | 265 ± 105 | ||||
| Ong | CS | 2018 | Y | 88 | 64/24 | 55 | 327 | 1 |
| N | 37 | 27/10 | 51 | 316 | ||||
| Santosh Kumar | RCT | 2017 | Y | 31 | NR | 43.4 ± 11.1 | NR | 2 |
| N | 33 | NR | 48.5 ± 11.6 | NR | ||||
| García Bernardo | CS | 2016 | Y | 23 | 21/2 | 55.3 ± 9.7 | 321 ± 108 | 1 |
| N | 23 | 20/3 | 57.7 ± 6.6 | 343 ± 100 | ||||
| T. Anila | RCT | 2015 | Y | 13 | NR | NR | 73.3 ± 25.1 | 2 |
| N | 13 | NR | NR | 74.9 ± 31.5 | ||||
| López-Andújar | RCT | 2013 | Y | 95 | 75/20 | 53.7 ± 7.68 | 316 ± 157 | 3 |
| N | 92 | 66/26 | 53.2 ± 8.68 | 297 ± 143 | ||||
| Weiss | RCT | 2009 | Y | 99 | 69/30 | 53.3 ± 9.8 | 597 ± 159 | 3 |
| N | 95 | 60/35 | 55.3 ± 6.7 | 559 ± 178 | ||||
| Lin | CS | 2007 | Y | 51 | 45/6 | 50.1 ± 10.0 | NR | 1 |
| N | 53 | 47/6 | 52.0 ± 10.0 | NR | ||||
| Li | CS | 2007 | Y | 33 | 30/3 | 47.2 ± 9.4 | 479 + 98 | 1 |
| N | 51 | 46/5 | 42.5 ± 13.5 | 457 + 89 | ||||
| Amador | RCT | 2005 | Y | 53 | 21/32 | 51.8 ± 9.4 | 362 | 3 |
| N | 54 | 24/30 | 50.6 ± 10.6 | 390 | ||||
| Elola-Olaso | CS | 2005 | Y | 50 | 29/71 | 51.93 ± 9.8 | NR | 1 |
| N | 50 | NR | ||||||
| Scatton | RCT | 2001 | Y | 90 | 62/28 | 48.3 ± 9.9 | 604 ± 194 | 3 |
| N | 90 | 58/32 | 49.2 ± 9.5 | 570 ± 153 | ||||
| Shimoda | CS | 2001 | Y | 76 | 33/43 | 51.8 ± 11.7 | NR | 1 |
| N | 71 | 32/39 | 52.9 ± 12.3 | NR | ||||
| Rabkin | CS | 1998 | Y | 118 | 43/75 | 47.7 | 610 | 1 |
| N | 44 | 7/37 | 48.0 | 522 | ||||
| Nuño | RCT | 1997 | Y | 50 | NR | NR | NR | 2 |
| N | 48 | NR | NR | NR | ||||
| Vougas | RCT | 1996 | Y | 30 | 12/18 | 42.0 | 678 | 3 |
| N | 30 | 13/17 | 45.0 | 696 | ||||
| Randall | CS | 1996 | Y | 59 | NR | NR | NR | 1 |
| N | 51 | NR | NR | NR |
Female/Male.
Mean ± standard deviation or mean.
Cold ischemia time.
NR: No reference; Y: Yes; N: No; CS: Comparative study; RCT: Randomized control trial; CIT: Cold ischemia time.
Measurements of outcomes provided in all studies
|
|
|
|
|
|
| Total biliary complications | López-Andújar | 2019 | 31/240 | 20/165 |
| Ong | 2018 | 26/88 | 3/37 | |
| García Bernardo | 2016 | 7/23 | 5/23 | |
|
| 2013 | 24/95 | 18/92 | |
|
| 2009 | 27/99 | 50/95 | |
| Li | 2007 | 10/33 | 6/51 | |
| Lin | 2007 | 5/51 | 9/53 | |
|
| 2005 | 32/53 | 6/54 | |
|
| 2001 | 30/90 | 14/90 | |
| Shimoda | 2001 | 25/76 | 11/71 | |
| Rabkin | 1998 | 43/118 | 11/44 | |
|
| 1997 | 5/50 | 16/48 | |
|
| 1996 | 5/30 | 6/30 | |
| Randall | 1996 | 13/59 | 7/51 | |
| Bile leak | López-Andújar | 2019 | 10/240 | 2/165 |
| Ong | 2018 | 2/88 | 1/37 | |
|
| 2017 | 11/31 | 4/33 | |
| García Bernardo | 2016 | 4/23 | 2/23 | |
|
| 2015 | 0/13 | 1/13 | |
|
| 2013 | 4/95 | 5/92 | |
|
| 2009 | 5/99 | 9/95 | |
| Li | 2007 | 4/33 | 1/51 | |
| Lin | 2007 | 1/51 | 1/53 | |
|
| 2005 | 2/53 | 3/54 | |
| Elola-Olaso | 2005 | 3/47 | 0/50 | |
|
| 2001 | 2/90 | 2/90 | |
| Shimoda | 2001 | 4/76 | 5/71 | |
| Rabkin | 1998 | 3/118 | 1/44 | |
|
| 1997 | 3/50 | 8/48 | |
|
| 1996 | 1/30 | 0/30 | |
| Randall | 1996 | 5/59 | 0/51 | |
| Biliary stricture | López-Andújar | 2019 | 11/240 | 14/165 |
| Ong | 2018 | 11/88 | 2/37 | |
|
| 2017 | 7/31 | 2/33 | |
| García Bernardo | 2016 | 2/23 | 3/23 | |
|
| 2015 | 1/13 | 2/13 | |
|
| 2013 | 2/95 | 14/92 | |
|
| 2009 | 7/99 | 8/95 | |
| Li | 2007 | 5/33 | 4/51 | |
| Lin | 2007 | 5/51 | 8/53 | |
|
| 2005 | 6/53 | 3/54 | |
| Elola-Olaso | 2005 | 6/44 | 4/46 | |
|
| 2001 | 3/90 | 6/90 | |
| Shimoda | 2001 | 5/76 | 6/71 | |
| Rabkin | 1998 | 7/118 | 10/44 | |
|
| 1997 | 1/50 | 8/48 | |
|
| 1996 | 2/30 | 6/30 | |
| Randall | 1996 | 8/59 | 7/51 | |
| Cholangitis | López-Andújar | 2019 | 6/240 | 0/165 |
| Ong | 2018 | 1/88 | 0/37 | |
|
| 2013 | 6/95 | 0/92 | |
|
| 2009 | 5/99 | 11/95 | |
| Li | 2007 | 1/33 | 1/51 | |
|
| 2005 | 8/53 | 0/54 | |
| Elola-Olaso | 2005 | 5/45 | 1/49 | |
|
| 2001 | 4/90 | 3/90 | |
|
| 1996 | 2/30 | 0/30 |
Bold typed studies indicate randomized control trials.
Figure 2Biliary strictures. A: In the period from 1995 to 2010, odds ratio (OR) for biliary strictures between “T-tube” group and “without T-tube” group was calculated with a fixed-effects model. The shape of diamond represents the overall effect of OR with 95% confidence interval (CI). The use of T-tube decreased the incidence of biliary strictures; B: In the period from 2010 to 2020, OR for biliary strictures between “T-tube” group and “without T-tube” group was calculated with a random-effects model. The shape of diamond represents the overall effect of OR with 95%CI. There was no significant difference between the two groups. OR: Odds ratio; CI: Confidence interval.
Meta-analysis of outcomes (all studies included)
|
|
|
|
|
|
|
|
|
|
|
| 1995-2010 | Overall biliary complications | 10 | 1246 | 1.41 [0.66, 2.98] |
|
| Egger: Bias = 1.92; | 3 × 4, 2 × 1, 1 × 5 | None |
| Bile leak | 11 | 1346 | 1.04 [0.63, 1.70] |
|
| Egger: Bias = 2.43; | 3 × 4, 2 × 1, 1 × 6 | None | |
| Biliary stricture | 11 | 1346 | 0.62 [0.42, 0.90] |
|
| Egger: Bias = -1.09; | 3 × 4, 2 × 1, 1 × 6 | With T-tube | |
| Cholangitis | 6 | 725 | 2.00 [0.59, 6.84] |
|
| Egger: Bias = 2.97; | 3 × 4, 1 × 2 | None | |
| 2010-2020 | Overall biliarycomplications | 4 | 763 | 1.49 [1.00, 2.22] |
|
| Egger: Bias = 2.50; | 3 × 1, 1 × 3 | Without T-tube |
| Bile leak | 6 | 853 | 1.91 [1.01, 3.64] |
|
| Egger: Bias = -1.69; | 3 × 1, 2 × 2, 1×3 | Without T-tube | |
| Biliary stricture | 6 | 853 | 0.76 [0.27, 2.12] |
|
| Egger: Bias = 0.84; | 3 × 1, 2 × 2, 1 × 3 | None | |
| Cholangitis | 3 | 717 | 7.21 [1.37, 38.00] |
|
| Egger: Bias = -12.51; | 3 × 1, 1 × 2 | Without T-tube |
Jadad scores × study number.
P < 0.05.
P < 0.01.
Odds ratio < 1 indicates the use of a T-tube. OR: Odds ratio; CI: Confidence interval.
Figure 3Overall biliary complications. A: In the period from 1995 to 2010, odds ratio (OR) for overall biliary complications between “T-tube” group and “without T-tube” group was calculated with a random-effects model. The shape of diamond represents the overall effect of OR with 95% confidence interval (CI). The use of T-tube had no influence on occurrence of overall biliary complication; B: In the period from 2010 to 2020, OR for overall biliary complications between “T-tube” group and “without T-tube” group was calculated with a fixed-effects model. The shape of diamond represents the overall effect of OR with 95%CI. The occurrence of overall biliary complications was significantly higher in “T-tube” group. OR: Odds ratio; CI: Confidence interval.
Figure 4Bile leaks. A: In the period from 1995 to 2010, odds ratio (OR) for peritonitis between “T-tube” group and “without T-tube” group was calculated with the fixed model. The shape of diamond represents the overall effect of OR with 95% confidence interval (CI). There was no significant difference between the two groups; B: In the period from 2010 to 2020, OR for peritonitis between “T-tube” group and “without T-tube” group was calculated with the fixed model. The shape of diamond represents the overall effect of OR with 95%CI. The incidence rate of bile leaks was significantly higher in “T-tube” group. OR: Odds ratio; CI: Confidence interval.
Figure 5Cholangitis. A: In the period from 1995 to 2010, odds ratio (OR) for cholangitis between “T-tube” group and “without T-tube” group was calculated with a random-effects model. The shape of diamond represents the overall effect of OR with 95% confidence interval (CI). There was no significant difference between the two groups; B: In the period from 2010 to 2020, OR for peritonitis between “T-tube” group and “without T-tube” group was calculated with a fixed-effects model. The shape of diamond represents the overall effect of OR with 95%CI. The incidence rate of bile leaks was significantly higher in “T-tube” group. OR: Odds ratio; CI: Confidence interval.
Sensitivity analysis of outcomes (only randomized control trials included)
|
|
|
|
|
|
|
|
|
|
|
| 1995-2010 | Overall biliarycomplications | 5 | 639 | 1.15 [0.28, 4.72] |
|
| Egger: Bias = 2.63; | 3 × 4, 2 × 1 | None |
| Bile leak | 5 | 639 | 0.56 [0.28, 1.13] |
|
| Egger: Bias = 1.72; | 3 × 4, 2 × 1 | None | |
| Biliary stricture | 5 | 639 | 0.45 [0.24, 0.85] |
|
| Egger: Bias= -2.78; | 3 × 4, 2 × 1 | With T-tube | |
| Cholangitis | 4 | 541 | 1.83 [0.36, 9.41] |
|
| Egger: Bias = 3.39; | 3 × 4 | None | |
| 2010-2020 | Bile leak | 3 | 277 | 1.38 [0.34, 5.65] |
|
| Egger: Bias = -1.94; | 3 × 2, 2 × 1 | None |
| Biliary stricture | 3 | 277 | 0.63 [0.06, 6.99] |
|
| Egger: Bias = 1.08; | 3 × 2, 2 × 1 | None |
Jadad scores × study number.
P < 0.05.
P < 0.01.
Odds ratio < 1 indicates the use of a T-tube. OR: Odds ratio; CI: Confidence interval.